Senior Director, Global Head of NBE DMPK
Merck KGaA
Frankfurt am Main, Hessen, Germany
Kyra Cowan is a Senior Director in Research and Development at Merck KGaA, leading as the Global Head of New Biological Entities Drug Metabolism and Pharmacokinetics (NBE DMPK), managing a department of scientific directors and scientists to represent the pharmacokinetic, bioanalytical, and immunogenicity strategies and scientific expertise across the large molecule portfolio, from concept phase to life cycle management. Prior to joining Merck, she was a drug development lead, manager, and scientist at Genentech in South San Francisco, California, where she served on and led teams for molecules in multiple therapeutic areas. She received a Ph.D. in Chemistry from Carleton University (Ottawa, Canada), and completed two postdoctoral fellowships, including one at the University of California, San Francisco, prior to entering industry.
Hot Topic: Rethinking the Immunogenicity Testing Paradigm for 21st Century Modalities
Monday, October 23, 2023
9:00 AM – 10:00 AM ET